Draft Genome Sequence of Lipopeptide-Producing Strain Pseudomonas fluorescens DSM 11579 and Comparative Genomics with Pseudomonas sp. Strain SH-C52, a Closely Related Lipopeptide-Producing Strain

Pseudomonas fluorescens DSM 11579 is known to be a producer of the lipopeptides brabantamide and thanamycin. Its draft genome gives insight into the complete secondary metabolite production capacity of the strain and builds the basis for a comparative study with Pseudomonas sp. strain SH-C52, a lipopeptide-producing strain involved in natural disease-suppressive soils. ABSTRACT Pseudomonas fluorescens DSM 11579 is known to be a producer of the lipopeptides brabantamide and thanamycin. Its draft genome gives insight into the complete secondary metabolite production capacity of the strain and builds the basis for a comparative study with Pseudomonas sp. strain SH-C52, a lipopeptide-producing strain involved in natural disease-suppressive soils.

[1]  S. Mehnaz,et al.  Draft Genome Sequence of Pseudomonas chlororaphis subsp. aurantiaca ARS-38, a Bacterial Strain with Plant Growth Promotion Potential, Isolated from the Rhizosphere of Cotton in Pakistan , 2020, Microbiology Resource Announcements.

[2]  Jan P. Meier-Kolthoff,et al.  TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy , 2019, Nature Communications.

[3]  S. Lee,et al.  antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline , 2019, Nucleic Acids Res..

[4]  G. Pessi,et al.  Biosynthesis of fragin is controlled by a novel quorum sensing signal , 2018, Nature Communications.

[5]  S. Mehnaz,et al.  The Systematic Investigation of the Quorum Sensing System of the Biocontrol Strain Pseudomonas chlororaphis subsp. aurantiaca PB-St2 Unveils aurI to Be a Biosynthetic Origin for 3-Oxo-Homoserine Lactones , 2016, PloS one.

[6]  Eric P. Nawrocki,et al.  NCBI prokaryotic genome annotation pipeline , 2016, Nucleic acids research.

[7]  Michael A. Skinnider,et al.  An automated Genomes-to-Natural Products platform (GNP) for the discovery of modular natural products , 2015, Nature Communications.

[8]  Ya-Ting Chang,et al.  Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options , 2015, Front. Microbiol..

[9]  P. Dorrestein,et al.  Genome mining and metabolic profiling of the rhizosphere bacterium Pseudomonas sp. SH-C52 for antimicrobial compounds , 2015, Front. Microbiol..

[10]  Roger G. Linington,et al.  Insights into Secondary Metabolism from a Global Analysis of Prokaryotic Biosynthetic Gene Clusters , 2014, Cell.

[11]  Walter Pirovano,et al.  SSPACE-LongRead: scaffolding bacterial draft genomes using long read sequence information , 2014, BMC Bioinformatics.

[12]  H. Sahl,et al.  Biosynthetic Origin of the Antibiotic Cyclocarbamate Brabantamide A (SB‐253514) in Plant‐Associated Pseudomonas. , 2014, Chembiochem : a European journal of chemical biology.

[13]  Glenn Tesler,et al.  Mapping single molecule sequencing reads using basic local alignment with successive refinement (BLASR): application and theory , 2012, BMC Bioinformatics.

[14]  W. Pirovano,et al.  Toward almost closed genomes with GapFiller , 2012, Genome Biology.

[15]  Nuno Bandeira,et al.  Mass spectral molecular networking of living microbial colonies , 2012, Proceedings of the National Academy of Sciences.

[16]  P. Bakker,et al.  Deciphering the Rhizosphere Microbiome for Disease-Suppressive Bacteria , 2011, Science.

[17]  S. Lindow,et al.  Genome-Driven Investigation of Compatible Solute Biosynthesis Pathways of Pseudomonas syringae pv. syringae and Their Contribution to Water Stress Tolerance , 2010, Applied and Environmental Microbiology.

[18]  A. Berti,et al.  Analysis of Achromobactin Biosynthesis by Pseudomonas syringae pv. syringae B728a , 2009, Journal of bacteriology.

[19]  W. Blankenfeldt,et al.  Phenazine compounds in fluorescent Pseudomonas spp. biosynthesis and regulation. , 2006, Annual review of phytopathology.

[20]  W. Achouak,et al.  Phenotypic and genomic evidence for the revision of Pseudomonas corrugata and proposal of Pseudomonas mediterranea sp. nov. , 2002, International journal of systematic and evolutionary microbiology.

[21]  S. Ready,et al.  SB-253514 and analogues; novel inhibitors of lipoprotein-associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. I. Fermentation of producing strain, isolation and biological activity. , 2000, The Journal of antibiotics.

[22]  D. Busby,et al.  SB-253514 and analogues: novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. II. Physico-chemical properties and structure elucidation. , 2000, The Journal of antibiotics.